President Donald Trump will return to a public meeting at the White House on Saturday, Oct. 10. The news was confirmed by the White House one day after the last medical report in which it was announced that President Trump’s health was continuing to improve and his exposure to the public was safe, according to Fox News. 

The White House on Thursday issued a memo signed by Dr. Sean Conley, the president’s physician, reporting that over the weekend, the president will be able to return to his commitments.

President Trump had contracted the Chinese Communist Party (CCP) Virus 10 days ago.

“Today, the President has completed his course of therapy for COVID-19 [CCP Virus] as prescribed by his team of physicians,” Conley said in his memo.

“Saturday will be day 10 since Thursday’s diagnosis, and based on the trajectory of advanced diagnostics the team has been conducting, I fully anticipate the President’s safe return to public engagements at that time,” he added.

The Centers for Disease Control established that people who suffered from the CCP Virus with mild to moderate symptoms remain infectious for up to 10 days after the onset of symptoms. Only people who suffered severe symptoms can remain infectious longer, said Fox News.

Saturday’s event, reportedly attended by President Trump, is a “law and order” meeting and will be held on the White House’s South Lawn. Co-founder of the “Blexit” group, conservative activist Candace Owens will lead the meeting.

The event aims to inform African American communities about the importance of the free market and entrepreneurship as an antidote to poverty, noting the advantages they have had since President Trump has been in office.

According to medical reports and President Trump’s videos and messages, his recovery from the virus was truly extraordinary and swift.

In a recorded message on Wednesday outside Walter Reed National Military Medical Center, President Trump praised the experimental drugs he received. The cocktail included a set of antibodies produced by the biotechnology company Regeneron.

“I was given Regeneron,” President Trump said in a video posted on his Twitter account Wednesday.

The medicine given to President Trump is still at the experimental stage. Its scientific name is REGN-COV2, and it’s a combination of two monoclonal antibodies, destined to fight SARS-CoV-2, which causes the CCP Virus. 

“The greatest benefit of the treatment was in patients who had not mounted an effective immune response, suggesting that REGN-COV2 could provide a therapeutic substitute for the natural immune response,” Regeneron President Dr. George Yancopoulos told the Wall Street Journal.

According to the Associated Press, pharmaceutical company Eli Lilly and Regeneron formally requested the Food and Drug Administration (FDA) on Wednesday to allow emergency use of their experimental antibody-based medicine. Early results suggest it reduces symptoms. So far, there has been no formal response from the FDA on any particular decision.

Both companies said that if the drug were approved for administration by the FDA, they could immediately produce about 1.5 million doses.